decisionhealth Newsletters, Coder Pink Sheets - 2005 Issue 3 (March)
Bolster medical necessity with correct diagnosis codes
Subscribe or sign in to view the full article.
Article Overview
This Q&A-style special report reviews diagnosis coding topics that affect whether services are supported by medical necessity. It is aimed at coders working in physician practices, pathology, orthopedics, emergency care, and related settings, and it covers broad guidance on ICD-9-CM diagnosis selection, screening and finding sequencing, hypertension reporting, congenital syndromes, pathology-based neoplasm coding, and situational E-code considerations.
Why This Topic Matters
Accurate diagnosis coding can influence claim acceptance, reporting consistency, and whether the documented reason for a service aligns with the record. The article helps readers compare common documentation scenarios and understand the kinds of coding issues that can lead to denials or miscoding concerns.
Article Sections
-
Introduction
Introduces the relationship between diagnosis coding and medical necessity, and frames the article as a Q&A special report based on an audioconference presentation.
-
Q&A: E codes and intentional versus accidental situations
Addresses diagnosis coding questions involving situational E codes in acute-care settings and discusses the general reporting context for these scenarios.
-
Q&A: Congenital syndromes without a specific ICD-9-CM code
Discusses how coders may approach congenital syndrome documentation when a single, specific code is not available in ICD-9-CM.
-
Q&A: Pathology specimens and the original malignancy
Covers how pathology coding relates to prior cancer diagnoses when evaluating a specimen from a follow-up procedure.
-
Q&A: Screening codes and findings for Pap smear coding
Reviews the order of diagnosis reporting when screening and test findings are both present in a cytology context.
-
Q&A: Dysplasia coding in ICD-9-CM
Explains a coding approach for pathology language describing more than one level of dysplasia in a biopsy report.
-
Q&A: Neoplasm coding when suspected cancer is not confirmed
Addresses how pathology coding should reflect a suspected neoplasm when the specimen does not confirm the working diagnosis.
-
Q&A: Hypertension diagnosis coding
Discusses the reporting of hypertension when documentation is limited and how the chart wording affects diagnosis selection.
-
Q&A: Neoplasm of uncertain behavior and PSA-related documentation
Covers a question about the use of an uncertain-behavior neoplasm code in connection with prostate-specific antigen testing and related diagnostic possibilities.
What You Will Learn
- How diagnosis coding relates to medical necessity in different care settings
- How situational E codes are discussed in acute-care documentation
- How congenital syndromes may be categorized when no exact ICD-9-CM code exists
- How pathology context affects diagnosis selection for follow-up specimens
- How screening diagnoses and findings are sequenced in cytology reporting
- How dysplasia reporting is handled when multiple severity levels are documented
- How suspected neoplasm coding differs when pathology does not confirm cancer
- How limited hypertension documentation affects ICD-9-CM diagnosis selection
Who Should Read This
- Medical coders
- Pathology coders
- Physician office billing staff
- Emergency department coders
- Orthopedic practice coders
- Compliance and revenue cycle staff
Codes Discussed
Code Ranges Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com